PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsBenznidazole
Benznidazole
Benznidazole (benznidazole) is a small molecule pharmaceutical. Benznidazole was first approved as Benznidazole on 2017-08-29. It is used to treat bacterial infections, chagas disease, and protozoan infections in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
Trade Name
FDA
EMA
Benznidazole
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Benznidazole
Tradename
Company
Number
Date
Products
BENZNIDAZOLECHEMO ResearchN-209570 RX2017-08-29
2 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
benznidazoleNew Drug Application2025-09-15
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
chagas diseaseEFO_0008559D014355B57
bacterial infections—D001424A49
protozoan infections—D011528B50-B64
Agency Specific
FDA
EMA
Expiration
Code
BENZNIDAZOLE, BENZNIDAZOLE, CHEMO RESEARCH SL
2024-08-29ODE-154
Patent Expiration
No data
ATC Codes
P: Antiparasitic products, insecticides and repellents
— P01: Antiprotozoals
— P01C: Agents against leishmaniasis and trypanosomiasis
— P01CA: Nitroimidazole derivatives, antiprotozoal agents against leishmaniasis and trypanosomiasis
— P01CA02: Benznidazole
HCPCS
No data
Clinical
Clinical Trials
24 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Chagas diseaseD014355EFO_0008559B57——1——1
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameBenznidazole
INNbenznidazole
Description
Benznidazole is a monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2-nitroimidazol-1-yl)acetic acid with the aromatic amino group of benzylamine. Used for treatment of Chagas disease. It has a role as an antiprotozoal drug. It is a member of imidazoles, a C-nitro compound and a monocarboxylic acid amide.
Classification
Small molecule
Drug classantiprotozoal substances (metronidazole type)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
O=C(Cn1ccnc1[N+](=O)[O-])NCc1ccccc1
Identifiers
PDB—
CAS-ID22994-85-0
RxCUI—
ChEMBL IDCHEMBL110
ChEBI ID—
PubChem CID31593
DrugBankDB11989
UNII IDYC42NRJ1ZD (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 3,759 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
66 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use